NASDAQ · XTLB
XTL Biopharmaceuticals Ltd.
Healthcare · Biotechnology
$1.70
Down-$0.03 (-1.45%)
Updated Nov 5, 2026, 3:02 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.63M
- P/E ratio
- -4.03
- Dividend yield
- 0.00%
- 52-week range
- $1.60 – $5.64
- Volume
- 9.55K
- Avg. volume
- 813.17K
Price performance · XTLB
XTLB price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
XTLB closed at $1.70 after 21 trading sessions, down 14.14% for the selected period.
- Last close
- $1.70
- Period change
- -14.14%
- Period low
- $1.61
- Period high
- $2.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $1.76 | $1.80 | $1.6101 | $1.70 | 9.55K |
| Nov 3, 2026 | $1.80 | $1.86 | $1.66 | $1.725 | 5.5K |
| Nov 2, 2026 | $1.61 | $1.8599 | $1.61 | $1.7001 | 12.98K |
| Oct 30, 2026 | $1.65 | $1.69 | $1.60 | $1.61 | 8.6K |
| Oct 29, 2026 | $1.90 | $1.90 | $1.76 | $1.76 | 7.06K |
| Oct 28, 2026 | $1.78 | $2.03 | $1.6501 | $2.01 | 7.68K |
| Oct 27, 2026 | $1.78 | $1.81 | $1.75 | $1.81 | 2.21K |
| Oct 26, 2026 | $1.89 | $1.89 | $1.82 | $1.82 | 4.09K |
| Oct 23, 2026 | $1.97 | $2.02 | $1.97 | $2.02 | 3.91K |
| Oct 22, 2026 | $1.86 | $1.97 | $1.78 | $1.97 | 10.36K |
| Oct 21, 2026 | $1.94 | $1.94 | $1.87 | $1.87 | 4.31K |
| Oct 20, 2026 | $1.94 | $1.94 | $1.94 | $1.94 | 986 |
| Oct 19, 2026 | $1.89 | $1.9599 | $1.89 | $1.9599 | 1.55K |
| Oct 16, 2026 | $1.94 | $2.0127 | $1.94 | $1.96 | 1.53K |
| Oct 15, 2026 | $1.86 | $2.01 | $1.86 | $1.91 | 7.43K |
| Oct 14, 2026 | $1.915 | $1.915 | $1.86 | $1.88 | 2.24K |
| Oct 13, 2026 | $1.926 | $1.9799 | $1.88 | $1.9799 | 4.29K |
| Oct 12, 2026 | $1.95 | $1.95 | $1.92 | $1.92 | 1.64K |
| Oct 9, 2026 | $1.98 | $2.03 | $1.98 | $1.98 | 8.8K |
| Oct 8, 2026 | $1.98 | $2.03 | $1.97 | $1.99 | 13.73K |
| Oct 7, 2026 | $2.02 | $2.05 | $1.975 | $1.98 | 27.82K |
Latest XTLB news
The latest Smart Investors Daily articles mentioning XTLB.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…
